The treatment of invasive fungal infections has deeply evolved in the last years with the inclusion of new antifungals, mainly new azoles (i.e., posaconazole, isavuconazole), to the therapeutic armamentarium. This review focuses on the role of isavuconazole for treating the most important invasive fungal infections both in animals and humans (hematological and non-hematological patients).
Pagano, L., Cattaneo, C., Quattrone, M., Oberti, M., Mazzitelli, M., Trecarichi, E. M., Isavuconazole-Animal Data and Clinical Data, <<JOURNAL OF FUNGI>>, 2020; 6 (4): 209-215. [doi:10.3390/jof6040209] [http://hdl.handle.net/10807/167069]
Isavuconazole-Animal Data and Clinical Data
Pagano, Livio;Quattrone, Martina;Trecarichi, Enrico Maria
2020
Abstract
The treatment of invasive fungal infections has deeply evolved in the last years with the inclusion of new antifungals, mainly new azoles (i.e., posaconazole, isavuconazole), to the therapeutic armamentarium. This review focuses on the role of isavuconazole for treating the most important invasive fungal infections both in animals and humans (hematological and non-hematological patients).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
